Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2005 1
2017 1
2018 2
2019 1
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Assessment of the Potential for Veverimer Drug-Drug Interactions.
Parsell D, Shao J, Guttendorf R, Mathur V, Li E, Wu YS, Tsao L, Tabakman S, Stasiv Y, Lee A, Biyani K, Klaerner G. Parsell D, et al. Among authors: biyani k. Drug Metab Dispos. 2021 Jul;49(7):490-500. doi: 10.1124/dmd.121.000366. Epub 2021 May 24. Drug Metab Dispos. 2021. PMID: 34031138 Clinical Trial.
Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease.
Klaerner G, Shao J, Biyani K, Kade M, Kierstead P, Gbur R, Tabakman S, Nguyen S, Buysse J. Klaerner G, et al. Among authors: biyani k. J Pharmacol Exp Ther. 2020 Dec;375(3):439-450. doi: 10.1124/jpet.120.000190. Epub 2020 Oct 8. J Pharmacol Exp Ther. 2020. PMID: 33033169